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The effect of guided imagery on anxiety, depression and vital signs in patients on 
hemodialysis 
 
Abstract 
Background and purpose: Patients on hemodialysis experience anxiety and depression. This 
study aimed to investigate the effect of guided imagery on anxiety, depression, and vital signs in 
patients on hemodialysis.  
Materials and methods: This randomized controlled clinical trial was conducted on 80 patients 
undergoing hemodialysis. The subjects were randomly assigned into two groups: a guided 
intervention group and a control group. The anxiety and depression were measured using the 
Hospital Anxiety and Depression Scale.  
Results: After the intervention, the level of anxiety and depression were significantly lower in 
the intervention group compared with the control group (p=0.030, p=0.001), respectively. A 
statistically significant reduction in the respiratory rate and heart rate was reported in the 
intervention group (p<0.05).   
Conclusion: Nurses are suggested to use guided imagery along with other interventions for the 
management of anxiety and depression. It is believed that it can alleviate adverse psychological 
responses among patients on hemodialysis. 
 
Keywords: Anxiety; Guided Imagery; Hemodialysis; Hypnosis; Mental Imagery. 
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1. Introduction 
Chronic renal failure (CRF) causes a progressive and irreversible destruction of renal function 
[1], and is frequently diagnosed at the advanced stages of the disease [2]. Patients with CRF 
usually need hemodialysis to increase their survival time. Hemodialysis involves cleaning blood 
through an artificial-kidney machine [3]. Patients on hemodialysis can experience both physical 
and psychological distress [4] and have the probability of hospitalization 1.5-3 times higher than 
other chronic diseases [5]. Hemodialysis requires that patients cope with a series of restrictions, 
such as fluid intake, diet regime, financial problems, hearing the distressing sounds of the 
hemodialysis device and frequent readmissions to the hospital due to exacerbation of the disease 
[6]. Mental health problems are prevalent among patients on hemodialysis and in particular 
anxiety and depression influence further their quality of life and length of hospital stay [7]. For 
instance, anxiety is a commonly overlooked psychiatric symptom in patients with CRF 
undergoing hemodialysis [1-3, 8]. The level of anxiety in these patients have been reported to be 
27%-45.7% [8]. The prevalence of severe depression and mild to moderate depression in 
hemodialysis has been reported as 22% and 25%, respectively [9].    
The signs and symptoms of anxiety and depression can be attributed to the presentations of CRF 
such as uremia [10]. While patients with CRF commonly experience psychological problems, 
they are not diagnosed, Also, the absence of a systematic psychiatric evaluation in the 
hemodialysis ward leads that patients do not receive appropriate care [11]. Therefore, the 
majority of patients with depression and anxiety are unaware of their mental health issues. The 
treatment of anxiety and depression in patients on hemodialysis requires effective assessment 
and planned interventions for the improvement of their mental wellbeing [12]. The treatment of 
mental health disorders needs both pharmacological and non-pharmacological methods [13]. 
Since hemodialysis patients need various medications that are eliminated mostly through kidneys 
[14], adding more medications to improve their mental health condition can lead to new health-
related problems. Also, pharmacological methods are costly and have potentials of harmful drug 
reactions. Therefore, the patients often decline to take new drugs, especially oral anxiolytics as 
the side effects associated with this group of drugs mitigates against their utility to treat patients 
on hemodialysis [8]. Therefore, there is a need to identify nonpharmacologic methods to 
manage patients’ mental health problems [8]. Non-pharmacologic methods including 
Complementary and Alternative Medicine (CAM) can relief their anxiety and depression [15] as 
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the incorporation of nontraditional treatment techniques into traditional patient care process. 
Such treatment modalities originate outside conventional Western medicine [16]. The National 
Center for Complementary and Integrative Health reports that the ten most common 
complementary health approaches among adults are natural products; deep breathing; yoga; 
chiropractic; meditation; massage; special diets; homeopathy; progressive relaxation; and guided 
imagery [17].  
Recent studies have shown that concentration on a mental image and thinking positively can 
have positive effects on one’s mood [18]. Guided imagery is a mind-body technique that uses 
mental images to promote relaxation and feelings of wellness. It can range from visualization 
and direct imagery-based suggestions to metaphor and storytelling [19], based on the perspective 
that the mind and body are interrelated and can have bilateral interactions. In guided imagery, the 
brain is activated to imagine an event in a positive and proactive manner prior to that an 
individual experience the actual event. In other words, the patient is guided to develop a 
desirable image mentally and to focus the imagination to feel, see, hear, and smell the event like 
a real event [20].  
CAM interventions have demonstrated beneficial clinical effects on anxiety and depression. 
Various CAM modalities have demonstrated success in alleviating anxiety and depression that 
are difficult to be managed through common treatment methods among patients on hemodialysis.  
In guided imagery, the subject’s thoughts and imagination are focused and directed toward a 
specific goal using a facilitator such as an audio recording. Guided imagery has the capacity to 
be integrated into traditional patient care in particular to alleviate pain and to promote relaxation. 
Guided imagery is designed to empower patients, to promote relaxation, and to guide patients to 
a place where they feel safe and relaxed. This is a low cost intervention and does not require 
specialized equipment or extensive education. Moreover, it is an easily organized technique and 
is not associated with adverse side effects. In guided imagery, the imagination is harnessed to 
help overcome physical symptoms and reduce psychological symptoms [21, 22]. The mechanism 
of action may be related to the power of guided imagery to send messages and data to the central 
nervous system and thus affect the body’s physiological processes. Guided imagery represents a 
basic principle of psychophysiology in that every thought has a physiologic reaction. When a 
mental image is experienced, there is an associated emotion that connects the feeling state with 
the mind and body leading to a physiologic change [19]. 
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The effects of guided imagery on anxiety and depression in patients on hemodialysis have not 
been discovered in previous studies. Therefore, the aim of this study was to investigate the effect 
of guided imagery on anxiety, depression and vital signs including systolic blood pressure [SBP], 
diastolic blood pressure [DBP], heart rate [HR], and respiratory rate [RR] in patients on 
hemodialysis.  
 
2. Materials and Methods 
2.1 Study design  
This quasi-randomized controlled clinical trial with a pre-intervention-post-intervention design 
was conducted from December 2015 to May 2016.  
2.2. Setting and sampling 
The study setting was a hemodialysis center in an urban area of Iran, which was supervised by 
nephrologists affiliated with a medical sciences university. The hemodialysis treatment 
modalities and characteristics of the patients were similar. Patients undergoing hemodialysis in 
the morning and afternoon work shifts were recruited into this study. Inclusion criteria were: 
undergoing hemodialysis three times a week for at least six months (so that they were used to the 
procedure and setting), between 35 and 65 years of age, ability to read and write in Farsi, having 
no hearing impairments, no previous history of psychiatric disorders, intact cognitive functions 
based on a general assessment by the Abbreviated Mental Test (AMT). The AMT assesses older 
individuals for the presence of cognitive disorders, and a score lower than seven out of ten 
indicates cognitive impairment [23]. The Cronbach alpha coefficient of the AMT has been 
reported as 0.76 [24]. Exclusion criteria were unwillingness to take part in this study, taking 
tranquillizer or sedative drugs four hours before the intervention, and hemodialysis instability.  
After obtaining permissions from the hemodialysis center, the researcher approached those 
patients who met the inclusion criteria and informed them of the aims and process of the study. 
Those patients that were willing to participate in this study signed the informed consent form. 
Patients were made aware that a refusal to participate would not affect their care.  
2.3. Sample size estimation 
Sample size calculation was based on a pilot study and the following power formula: 
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Given 95% confidence interval, alpha 0.5 and 10% samples’ dropout, 40 patients in each group 
were needed for the rejection of the null hypothesis.   
2.4. Randomization 
A total of 80 subjects were randomly assigned into the intervention (n = 40) or control group (n 
= 40). A random sequence allocation method using permuted block randomization with the 
allocation ratio of 2:2 was used. Random allocation sequences were determined using the table 
of random numbers. Randomization allocation sequences were generated by a separate 
investigator, that assigned the patients to the groups. The sampling process continued until a 
sufficient number of the subjects were recruited into each group. A staff nurse, who was blind to 
the allocation of the patients, extracted the required data from patients’ files, assessed their vital 
signs and calculated the Hospital Anxiety and Depression Scale (HADS) scores (Figure 1).  
2.5. Data collection and measurements 
 Three data sources were utilized: 
a) Demographic characteristics including age, gender, the marital status, education level, length 
of hemodialysis treatment, smoking, employment status, marital status, history of hemodialysis 
and dry weight (i.e. the patient’s normal weight without the fluid buildup that is removed by 
hemodialysis) were collected (Table1). Data was accessed from the subjects’ medical files and 
by interviewing. 
b) Vital signs were measured and recorded. BP was measured on subjects’ left arm (without 
fistula) using a mercury sphygmomanometer. The RR was also measured by a nurse for one 
minute without the patient being aware of the measurement. Also, instead of a manual 
measurement of pulse rate, the heart rate (HR) was monitored using a standard and calibrated 
monitoring machine manufactured by SAIRAN®. 
c) The Hospital Anxiety and Depression Scale (HADS) was utilized to collect data on anxiety 
and depression levels. The HADS measures distress quantitatively and has two subscales: 
‘anxiety’ and ‘depression’, but it is not a categorical measure of clinical diagnoses [25]. The 
HADS has been developed by Zigmond and Sanith to identify the indices of anxiety and 
depression among patients in non-psychiatric care settings. It is consisted of 14 items with two 
subscales of anxiety (HADS-A) and depression (HADS-D). Each subscale contains 7 items as 
follow: anxiety items: 1, 3, 5, 7, 9, 11 and 13; depression items: 2, 4, 6, 8, 10, 12 and 14. The 
anxiety and depression subscales have a 4-point Likert scale from 0 (absence of symptoms) to 3 
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(the maximal presentation of symptoms). Scores for each anxiety and depression subscales range 
from 0 to 21 and scores are categorized as follows: normal: 0–7, mild: 8–10, moderate: 11–14 
and severe: 15–21 [26]. Therefore, a higher score indicates a higher level of anxiety or 
depression. Scores 8 or above on the anxiety or depression subscales indicate the possibility of 
either anxiety or depression disorders [27]. The quantitative scoring of both subscales ranges 
from 0 to 27. Scores equal to or greater than five are associated with mild anxiety or depression. 
Scores equal to or greater than ten suggest moderate anxiety or depression. Scores equal to or 
greater than 15 indicate moderately severe anxiety or depression, whilst scores equal to or 
greater than 20 signify severe anxiety or depression [28]. The Farsi version of the HADS is 
acceptable as a valid and reliable tool for determining psychological distress, in which the 
Cronbach’s alpha coefficient was reported as 0.78 for anxiety and 0.86 for depression subscales 
[29]. 
2.5. Intervention 
The intervention group received the guided imagery intervention three times per week over four 
weeks, alongside their routine care, assisted by a certified psychologist. Thirty minutes prior to 
hemodialysis, the patients were requested to assume a comfortable position and to close their 
eyes. They were instructed to take deep abdominal and diaphragmatic breaths and to relax their 
muscles, while imagining a beautiful scenery. At the same time, they were listening to various 
nature sounds including the sound of falling water, sea waves, chirping jungle birds, and rain 
falling. Subjects were asked to imagine being in the place that the audio-recording depicted (e.g. 
the jungle or at the seaside). They were instructed to try hearing and smelling this places and so 
put themselves in the scene that the audio-recording depicted. The subjects wore disposable 
headphones (Sony, MDR-XD100®), that were attached to a device playing the sounds (Lenovo, 
G410®) so as to prevent environmental noise from distracting their attention and to ensure their 
concentration on the audio-recording. The device was placed so that the subjects could use it 
comfortably when they were sitting in a bed or a chair. To stimulate their imagination and enable 
them to feel relaxed, the subjects were instructed to listen to it 30 minutes before the 
commencement of hemodialysis [30].  
The control group received routine care, which entailed recording of vital signs and weight and 
connection to the dialysis machine. Efforts were made by nursing staff to proceed silently within 
the unit and so prevent any confounding sounds. According to the Iran’s standard clinical policy 
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at the hemodialysis unit, no patient companion is allowed to enter the unit during hemodialysis 
[31].  
Blinding was impossible to be applied in the sample selection due to the nature of the 
intervention. However, the statistical analyzer was unaware of group assignments, thus aiding 
impartiality. Only after completion of statistical data analysis, the results disclosed to the 
researcher. 
Both groups completed the HADS scale and their had vital signs measured before the 
intervention and immediately after the intervention. The mean scores of the severity of anxiety 
and depression were calculated in each group.  
2.6. Statistical analysis 
The Statistical Package for the Social Sciences software (SPSS, version 21.0, SPSS Inc., 
Chicago, IL, USA) was used for data analysis. Descriptive statistics (frequency, percentage, 
mean, standard deviation) and inferential statistics (independent t-test, 2 test, Cramer V test, 
Fisher's exact test, and Cohen test) were used for the presentation of findings. The Kolmogorov 
Smirnov test (K-S) was applied to examine the normal distribution of the data. The level of 
statistically significance was defined as P< 0.05.  
2.7. Ethical considerations 
This study was approved by the ethics committee affiliated with Shahed University (Protocol 
number: Shahed.REC.1394.64), that was conducted in compliance with the Declaration of 
Helsinki 1995, revised 2001. Also, necessary permissions were sought from the hospital 
authorities to enter the research zone. All patients were assured of anonymity and confidentiality 
of data. They had the right to refuse participation or withdraw from the study at any time. This 
study was performed under the supervision of a nephrologist in the hemodialysis center to 
intervene in case of any negative consequence of the intervention, but no side effects were 
reported during the study.  
3. Results 
3.1. The demographic characteristics of the patients 
The samples were 47 male (58%) and 33 female (42%) hemodialysis patients with a mean age of 
47.21 ± 8.34 years. The minimum and maximum age was 35and 65 years. Sixty-six patients 
were married (82.5%) and fourteen were single (17.5%). The results of the t-test, Fisher’s exact 
test and 2 test showed no statistically significant differences between the groups in terms of  
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demographic variables including age, gender, the education level, marital status, occupation 
status, and duration of hemodialysis (Table 1). 
3.2. Hospital anxiety and depression scale (HADS) scores 
After the guided imagery intervention, the level of anxiety was significantly lower in the 
intervention group compared with the control group (X2= 6.96, df = 3, p =0.030). According to 
the Cramer V2 test, the correlation between the intervention and patients’ level of anxiety was 
moderate (v2 = 0.295). 
In the intervention group, the mean scores of  anxiety before and after the intervention were 
12.12±3.24 and 10.50±3.31, respectively. In the control group, they were as 12.60±3.34 and 
12.30±3.42, respectively. The effect size of the difference in the anxiety level between the 
groups was reported as 0.69 demonstrating a medium effect size of the guided imagery 
intervention (Table 2). 
In relation to the  level of depression after the guided imagery intervention, level of depression 
was significantly lower in the intervention group compared with the control group (X2=9.133, df 
= 3, p = 0.001). Also, the Cramer V2 test revealed a moderate correlation between the guided 
imagery intervention and the level of depression (v2 = 0.33).  
In the intervention group, the mean scores of patients’ depression before and after the 
intervention were reported as 10.82±2.70 and 10.02±2.58, respectively. Similarly, in the control 
group, it was changed from 11.55±2.29 to 11.65±2.33. The effect size of the difference in the 
depression level between the groups was reported as 0.62 demonstrating a medium effect size of 
the guided imagery intervention (Table 2).  
3.3. Vital signs 
The comparison of vital signs between the groups was shown in Table 3. There were no 
statistically significant differences between the groups before the intervention. While SBP, RR 
and HR significantly reduced after the intervention, no statistically significant difference was 
found in DBP in the intervention group after the intervention. The assessment of the Cohen test 
demonstrated a large effect size in SBP, a large effect size in RR, but showed a small effect size 
in HR (Table 3).  
4. Discussion 
The present study was conducted to assess the effect of guided imagery on anxiety, depression, 
and vital signs among patients undergoing hemodialysis. After the guided imagery intervention, 
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the levels of anxiety and depression was improved. SBP, HR and RR were reduced, but despite 
reductions in DBP, it showed no statistically significant reduction.  
The findings of this study indicated that guided imagery could reduce anxiety and depression in 
patients undergoing hemodialysis. Guided imagery and other similar techniques can be applied 
as non-pharmacologic interventions, with no reported negative consequences on patients’ health, 
to reduce anxiety and depression in patients undergoing hemodialysis. 
In this study, the guided imagery intervention played a significant role in reducing the levels of 
anxiety and depression in the intervention group. There were statistically significant differences 
in the mean and standard deviation of anxiety and depression in the control and intervention 
groups. Similarly, Antall (2004) reported that guided imagery reduced anxiety, pain, duration of 
hospital stay, and the amount of painkillers used by patients [32]. Also, Gonzales (2010) and 
Forward et al. (2015)  note d that guided imagery had a significant role in the reduction of anxiety 
[33,34]. Aboghasemi et al. (2010) found that guided imagery had a significant positive effect on 
anxiety, depression and hope for treatment (treatment expectancy) in women suffering from 
cancer [35].   
Halpin et al. (2002) studied the effect of guided imagery on the level of anxiety, pain, 
satisfaction with treatment, length of hospital stay and treatment cost in patients undergoing the 
heart surgery. They showed that indicate guided imagery reduced patients’ anxiety, length of 
hospital stay and treatment cost, and also increased their satisfaction [36]. Patricolo et al. (2017) 
showed that guided imagery effectively reduced anxiety in patients and improved their sleep 
status [37]. 
This study reported significant differences between the levels of anxiety and depression in the 
intervention group before and after guided imaginary. Comparison of the levels of anxiety and 
depression using the HADS tool before and after the intervention revealed some improvements 
in intervention group. These findings are promising and suggest that guided imagery could 
reduce anxiety and depression in this patient group. Some studies contradicted claims for the 
effectiveness of guided imagery. Krespi  et al. (2016) studied the effect of visual imagery on the 
adjustment and quality of life of hemodialysis patients. Their findings indicated that the 
intervention did not have any effect on emotional adjustment or quality of life after the 
intervention and at follow-up. Nevertheless, the rate of patients’ compliance with the 
intervention was moderately high and patients reported that they were satisfied with the 
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intervention procedure [38]. Thomas et al. (2010) also studied the reduction of anxiety in patients 
after the joint arthroplasty surgery and concluded that guided imagery had no statistically 
significant effect on the reduction of patients’ anxiety [39]. Foji (2015) studied the effect of 
guided imagery on the anxiety level and hemodynamic measures in patients undergoing coronary 
angiography. It was shown that guided imagery had a significant effect on the reduction of 
anxiety, but the mean scores of hemodynamic symptoms before and after the intervention were 
not significantly different [40], and also no significant effect on BP was reported after the 
intervention. Contradictions in results can be attributed to differences in sampling process, 
subjects and contextual factors influencing patients’ feelings of anxiety and depression during 
hospitalization.  
In this study, guided imagery resulted in an increase in the body’s parasympathetic activities  
leading to some changes in the physiological reactions, that in turn reduced anxiety and 
depression levels. The use of non-pharmacological methods to decrease anxiety and depression 
levels is advised in that they are safe and easy to use. Also, they do not require specific locations 
and equipment and the harmful side effects of pharmacological treatments can be avoided.  
As the limitation of this study, the patients were not free to choose when to listen and how many 
times to listen to the audio-recording. Additionally, illiterate patients were not included in the 
study as the HAS tool should be self-completed. The patients could not become blind to the 
intervention due to the nature of guided imagery. There is a lack of enough knowledge of CAM 
such as guided imagery among healthcare providers in Iran. Also, a few studies are available 
regarding the effect of guided imaginary on patients’ wellbeing, which needs further invitations 
by future researchers. Since the completion of the questionnaires using patients’ interviews 
might have affected the patients’ answers, the use of other scales with pictures or numeric scales 
is suggested. In this study, a control group rather than a placebo group was used so the difference 
between guided imagery and placebo remains unclear, and needs future investigations.  
Conclusion 
This study showed that the patients’ levels of anxiety and depression, and their RR and HR were 
improved by guided imagery. This study can be replicated with a larger sample size undergoing 
hemodialysis to examine the generalizability of findings to other contexts. It is suggested to 
compare the effects of guided imagery techniques with other relaxing techniques on patients’ 
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wellbeing. Also,  it can be replicated with illiterate participants, and empower patients to choose 
the type of music to listen to and when to listen. 
Providing patients with the opportunity to verbalize their perspectives of whether guided imagery 
was beneficial, or if they would recommend it to others, can provide additional insights for 
utilizing this intervention in healthcare settings.  
It is suggested that future research is conducted to study the benefits of guided imagery on 
hemodialysis patients’ anxiety and depression over time to support the efficacy of guided 
imagery in patients’ anxiety and depression. Anxiety and depression may continue throughout 
the treatment process, guided imagery should be repeated over time with subsequent 
measurements of anxiety and depression.  
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Table 1. The demographic characteristics of the patients in the groups 
 
* P values indicated the statistical significance of differences between the intervention and control 
groups using the independent t-test and chi-square test.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Characteristics 
 
Total 
(n = 80) 
Intervention 
group 
(n = 40) 
Control 
 group 
(n = 40) 
Statistical test 
and 
p value 
Age (year) 
Mean ± SD 
 
47.21 ± 8.34 
 
47.20 ± 8.36 
 
47.22 ± 5.43 
t=-0.013 
df=78 
p =0. 980 
Gender, n (%) 
Female  
Male 
 
33(41.25%) 
47(58.75%) 
 
16(48.50%) 
24(51.10%) 
 
17(51.50%) 
23(48.90%) 
Fisher's exact test  
df=1 
p =0.520 
Education level, n (%) 
Primary school 
Secondary school 
Tertiary education 
 
24(30.00%) 
45(56.25%) 
11(13.75%) 
 
13(32.50%) 
21(52.50%)      
 6(15.00%) 
 
11(27.50%) 
24(60.00%) 
5(12.50%) 
x
2
 = 0.59 
df=2 
p =0. 890 
 
Marital status, n (%) 
Single  
Married 
 
14(17.50%) 
66(82.50%)  
 
  8(20. 00%) 
32(80.00%)  
 
6(%15.00) 
34(%85.00) 
Fisher's exact test  
df=1 
p =0.770 
Occupation status, n (%) 
Unemployed 
Employee 
Retired 
Housewife 
 
20(25.00%) 
17(21.25%) 
17(21.25%)  
26(32.20%) 
 
  9(22.50%)  
9(22.50%) 
10(25.00%) 
12(30.00%) 
 
11(27.50%)  
8(20.00%) 
7(17.50%)  
14(35.00%) 
x
2
 =1.41 
df=3 
p =0. 840 
 
 
Place of residence, n (%) 
Urban 
Rural 
 
67(72.25%) 
25(27.75%) 
 
34(66.70%) 
 6(33.30%) 
 
33(77.70%) 
 7(23.30%) 
Fisher's exact test  
df=1 
p =0. 990 
Smoking, n (%) 
Yes 
No 
 
17(21.25%) 
63(78.75%) 
 
 9(22.50%) 
31(77.50%) 
 
 8(20.00%) 
32(80.00%) 
Fisher's exact test  
df=1 
p =0. 990 
Duration of hemodialysis 
(hour) Mean ± SD 
 
 
7.02 ± 6.00 
 
6.62 ± 5.00 
 
7.42 ± 6.91 
 
t =0.593 
df=71.04 
p =0. 550 
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Table 2. The comparison of the levels of anxiety and depression before and after the intervention  
 
 Note: *P-values indicated the statistical differences between the groups using the chi-squared test for 
the qualitative rating system of anxiety and depression. P-values were reported for the quantitative 
rating system using the t-test after considering the equality of variances.  
Variables 
Intervention  
 group 
(n %) 
Control 
group 
(n %) 
Statistical test 
 and p -value 
95%CI 
Std. Error 
Homogenous 
 
Before the intervention 
Anxiety 
Normal 
Mild 
Moderate 
Severe               
 
 
0(00.0) 
5(12.5) 
7(17.5) 
28(70.0)  
 
 
0(00.0) 
4(10.0) 
9(22.5) 
27(67.5)  
 
 
X2=1.553 
df=2 
 Pa=0.460 
 
 
 
-2.21,1.06 
 
            
 
          Yes 
       
QRS 
(Mean ± SD) 12.12±3.24 12.60±3.34 
Leven’s 
test=0.38 
t=-0.699 
df=78 
p=0.486 
 
        
 
         Yes 
Depression  
Normal  
Mild 
Moderate 
              Severe 
 
 
0(00.0) 
 5(12.5) 
8(20.0) 
27(67.5)  
 
0(00.0) 
2(5.0) 
 8(20.0) 
30(75.0) 
 
 
X2=0.57 
df=2 
 P=0.751 
 
 
 
 
-1.84,0.39 
 
 
          Yes 
 
       
      QRS 
(Mean ± SD) 10.82±2.70 
 
11.55±2.29 
 
Leven’s 
test=0.48 
t=-1.261 
df=78 
p=0.200 
 
               
 
          Yes 
     After the intervention 
Anxiety          
Normal 
Mild 
Moderate 
Severe 
 
2(5.0) 
9(22.5) 
10(25.0)  
19(47.5) 
 
0(11.1) 
4(10.0) 
11(27.5) 
25(62.5)  
 
 
X2=6.96 
df=3 
P=0.030 
 
 
 
 
-3.58,-0.61 
 
       No 
Phi=0.295 
Cramer’s v2=0.295 
Small effect 
QRS 
(Mean ± SD) 
 
10.50±3.31 
 
 
12.30±3.42 
 
Leven’s 
test=0.87 
t=-2.819 
df=78 
p=0.006 
 
No 
Cohen's d=0.69 
r=0.32 
Medium effect 
Depression                      
Normal 
Mild 
Moderate 
Severe               
 
1(2.5) 
9(22.5) 
12(30.0) 
18(45.0) 
 
 0(00.0) 
3(7.5) 
 8(20.0) 
29(72.5) 
 
 
X2=9.133 
df=3 
 P=0.01 
 
 
-2.62,-0.42 
        No 
Phi=0.338 
Cramer’s v2=0.338
Medium effect 
 
             
QRS 
(Mean ± SD) 10.02±2.58 11.65±2.33 
Leven’s 
test=0.62 
t=-2.76 
df=78 
p=0.007 
 
No 
Cohen's d=0.62 
r=0.29 
Medium effect 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
3 
 
The Cramer’s v2 showed the correlation between the intervention, anxiety and depression. 
Cohen’s d represented the effect size of the intervention on anxiety and depression, while considering 
their qualitative scoring systems. QRS stands for the quantitative rating system. 
 
Table 3. The comparison of physiologic symptoms before and after the intervention 
Symptom Group SBP 
Mean±SD 
DBP  
Mean± SD 
 
HR 
Mean±SD 
 
RR  
Mean±SD 
Before the 
intervention 
 
Statistical test  
p-value  
 
 
Control  
Intervention 
 
 
132.85±13.22 
129.22±12.70 
 
Leven’s=0.80 
t=-1.25 
df=78 
p=0.210 
81.75±8.51 
82.50±11.32 
 
Leven’s=0.058 
t=0.335 
df=78 
p=0.730 
75. 42±8.56 
77. 95±6. 97 
 
Leven’s=0.216 
t=1.44 
df=78 
p=0. 150 
16.10±1. 90 
16.75±1.61 
 
Leven’s=0.396 
t=1.64 
df=78 
p=0.104 
After the 
intervention 
 
Statistical test  
p-value 
Control  
Intervention  
 
 
 
 
134.87±12.68 
121.75±12.73 
 
Leven’s=0.87 
t=-4.61 
df=78 
p=0.001 
81.87±8. 14 
81.00±10.32 
 
Leven’s=0.234 
t=-0. 419 
df=78 
p=0.670 
77.22±7.92 
73.75±6.25 
 
Leven’s=0.354 
t=-2.17 
df=78 
p=0.030 
16.95±1.66 
14.40±0.98 
 
Leven’s=0.015 
t=-8.35 
df=78 
p=0.001 
Effect size 
(Cohen’s d) 
 d=1.03 
r=-0.45 
Large. effect 
 d=0.49 
r=-0.24 
Small. effect 
d=1.87 
r=-0.68 
large effect 
* (p <0.05) 
Data are represented as means ± standard deviation. P-values indicated differences between the groups 
using the independent t-test by considering the equality of variance.  
Cohen’s d represented the effect size of the intervention on physiologic parameters. 
SBP: systolic blood pressure, DBP: diastolic blood pressure, HR: heart rate,  RR: respiratory rate 
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Figure 1. The process of the study according to the Consort flow diagram (2010) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Assessed for eligibility (n=80) 
Excluded (n=0) 
   Not meeting inclusion criteria (n=0) 
 
 
Analysed (n=40) 
 Excluded from analysis (give reasons) (n=0) 
Lost to follow-up (give reasons) (n=0) 
Discontinued intervention (give reasons) (n= 0) 
Allocated to intervention (n= 40) 
 Received allocated intervention (n= 40) 
 Did not receive allocated intervention (give 
reasons) (n=1, absent from the sessions) 
Lost to follow-up (give reasons) (n=0) 
Discontinued intervention (give reasons) (n= 0) 
Allocated to control (n= 40) 
 Received allocated intervention (n= 40) 
 Did not receive allocated intervention (give 
reasons) (n=1, absent from the sessions) 
Analysed (n=40) 
 Excluded from analysis (give reasons) (n=0) 
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Analysis 
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• Anxiety and depression are prevalent among patients on hemodialysis; 
• Complementary and Alternative Medicine (CAM) can help reduce anxiety and 
depression; 
• In guided imagery as one type of CAM, the imagination is harnessed to help overcome 
physical symptoms and reduce psychological symptoms; 
• Guided imagery in this study improved the patients’ experiences of anxiety and 
depression. 
 
